March 1, 2017
Tolero Pharmaceuticals, a US biotech startup specializing in cancer and hematologic disorders, which was recently acquired by Sumitomo Dainippon Pharma, aims to submit a new drug application (NDA) for its CDK9 inhibitor alvocidib for acute myeloid leukemia (AML) in the...read more